Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26030969 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mariana Gallo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Metabolome, Metabolomics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo per l’Incentivazione alla Ricerca FIR2021, Nicoletta Bianchi and Fondo interdisciplinare per la Ricerca Dipartimentale FIRD2022, Laboratorio per le Tecnologie delle Terapie Avanzate of the University of Ferrara.
Abstract (Originalsprache)
Breast Cancer (BrCa) exhibits a high phenotypic heterogeneity, leading to the emergence of aggressive clones and the development of drug resistance. Considering the BrCa heterogeneity and that metabolic reprogramming is a cancer hallmark, we selected seven BrCa cell lines with diverse subtypes to provide their comprehensive metabolome characterization: five lines commonly used (SK-Br-3, T-47D, MCF-7, MDA-MB-436, and MDA-MB-231), and two patient-derived xenografts (Hbcx39 and Hbcx9). We characterized their endometabolomes using 1H-NMR spectroscopy. We found distinct metabolite profiles, with certain metabolites being common but differentially accumulated across the selected BrCa cell lines. High levels of glycine, lactate, glutamate, and formate, metabolites known to promote invasion and metastasis, were detected in all BrCa cells. In our experiment setting were identified unique metabolites to specific cell lines: xanthine and 2-oxoglutarate in SK-Br-3, 2-oxobutyrate in T-47D, cystathionine and glucose-1-phosphate in MCF-7, NAD+ in MDA-MB-436, isocitrate in MDA-MB-231, and NADP+ in Hbcx9. The unique and enriched metabolites enabled us to identify the metabolic pathways modulated in a cell-line-specific manner, which may represent potential candidate targets for therapeutic intervention. We believe this study may contribute to the functional characterization of BrCa cells and assist in selecting appropriate cell lines for drug-response studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
- Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
ORCID-Profile: Mariana Gallo, Anna Terrazzan, Pietro Ancona, Stefano Volinia, Thelma A Pertinhez, Nicoletta Bianchi
Förderung
- Fondo per l’Incentivazione alla Ricerca FIR2021
- Nicoletta Bianchi and Fondo interdisciplinare per la Ricerca Dipartimentale FIRD2022
- Laboratorio per le Tecnologie delle Terapie Avanzate of the University of Ferrara
Zitieren
APA
Gallo, M., Ferrari, E., Brugnoli, F., Terrazzan, A., Ancona, P., Volinia, S., Bertagnolo, V., Bergamini, C. M., Spisni, A., Pertinhez, T. A., & Bianchi, N. (2025). Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26030969
Vancouver
Gallo M, Ferrari E, Brugnoli F, Terrazzan A, Ancona P, Volinia S, et al. Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26030969
BibTeX
@article{Gallo2025,
author = {Gallo, Mariana and Ferrari, Elena and Brugnoli, Federica and Terrazzan, Anna and Ancona, Pietro and Volinia, Stefano and Bertagnolo, Valeria and Bergamini, Carlo M and Spisni, Alberto and Pertinhez, Thelma A and Bianchi, Nicoletta},
title = {Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26030969}
}
EUVIMED